STOP GAMES Act of 2026
Rep. Sorensen and Rep. Bice Introduce Bipartisan Bill to Stop Drug Companies From Delaying Cheaper Generics
The STOP GAMES Act of 2026 is currently in the early stages of the legislative process. It was recently sent to the House Committee on Energy and Commerce for review. There are no upcoming votes scheduled at this time.
Legislative Progress
Lowering drug costs is a popular goal for both parties, but many bills like this struggle to get a final vote in a crowded schedule.
Key Points
Impact Analysis
Personal Impact
Life & Work
Small business owners who provide health insurance for their employees face rising prescription drug costs. Faster generic drug approvals could lower the cost of employer-sponsored drug coverage over time, providing some relief to small businesses struggling with healthcare expenses.
Programs
Disabilities
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
STOP GAMES Act of 2026
Data Sources
Sponsor
Cosponsors
(1)Analysis generated by AI. Always verify with official sources.